-
Group Medical EOI - U.S. Benchmarking Survey Identifies Underwriting Challenges
By Joe Iannetti Feb 11, 2020 English
In the fourth quarter of 2019, Gen Re released the results of our Group Medical Evidence of Insurability Underwriting Survey. The survey focused on how companies staff for and process their Evidence of Insurability (EOI) applications; it included Group...
Read More -
World Cancer Day - Celebrating a Decline in U.S. Cancer Mortality
By Jean-Marc Fix Feb 04, 2020 English
When the Cancer Statistics, 2020 report was released a few weeks ago, the press rightfully basked in the great news: In the U.S. there were 2.9 million fewer cancer deaths than there would have been if the historically increasing cancer rates had remained...
Read More -
Another Coronavirus Outbreak - What Should Insurers Do?
By Ross Campbell Jan 28, 2020 English
The news of an outbreak in China of a new type of coronavirus (2019-nCoV), leading to respiratory illness, recalls previous potential pandemic infections. Coronavirus was behind SARS (Severe Acute Respiratory Syndrome) in 2002 and MERS (Middle East Respiratory...
Read More -
Understanding Viral Hepatitis - What’s Relevant to Underwriting?
By Dr. Sandra Mitic and Annika Tiedemann Jan 23, 2020 English
Prevalence, current therapies and prevention are the key themes for insurers that are reviewing their approach to applications with a history of viral hepatitis. As its name suggests, viral hepatitis is the term used to describe diffuse inflammation of...
Read More
